Risk factors for occult mediastinal lymph node involvement in clinical stage I lung cancer

P. Van Schil

Source: Breathe 2007; 4: 163
Journal Issue: December
Disease area: Thoracic oncology

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Van Schil. Risk factors for occult mediastinal lymph node involvement in clinical stage I lung cancer. Breathe 2007; 4: 163

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Microbiological study of mediastinal lymph node biopsy from patients with sarcoidosis and lung cancer
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018




Central tumor location and presence of occult lymph node metastasis in cT1N0M0 NSCLC
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019


Secondary lymph node involvement in patients with pulmonary metastases
Source: Eur Respir J 2007; 30: Suppl. 51, 273s
Year: 2007

Lung cancer size and thoracic lymph nodes metastatic involvement: a correlation
Source: Eur Respir J 2004; 24: Suppl. 48, 671s
Year: 2004

Lung cancer size and thoracic lymph nodes metastatic involvement: A correlation
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011

The role of PET-CT in mediastinal lymph node staging in NSCLC
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Role of molecular and cellular techniques applied to EBUS-TBNA of mediastinal lymph nodes for lung cancer staging
Source: Annual Congress 2012 - EBUS-TBNA: a never ending story
Year: 2012

Probability model for malignancy in hilar and mediastinal lymph nodes in lung cancer based on PET-CT and EBUS
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019


Is the highest mediastinal lymph node a prognostic factor in stage IIIA N2 NSCLC?
Source: ISSN=ISSN 1810-6838, ISBN=, page=355
Year: 2006

Sampling of ipsilateral mediastinal nodes by EBUS-TBNA in lung cancer staging
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012

An usual metastasis of squamous cell lung cancer: intra-abdominal lymph nodes
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019



A study of the presence of unexpected granulomatous disease in lymph nodes excised during surgery for suspected or known breast cancer
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016


Impact of endoscopic ultrasound in the staging of lung cancer patients: does lymph node size matter?
Source: Eur Respir J 2007; 30: Suppl. 51, 452s
Year: 2007

A study on the identification of the sentinel node in the lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 14s
Year: 2001

Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 206s
Year: 2007

N3 hilar sampling decision in the staging of mediastinal lung cancer
Source: ERJ Open Res, 7 (3) 00116-2021; 10.1183/23120541.00116-2021
Year: 2021



Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy
Source: Eur Respir J 2006; 28: Suppl. 50, 82s
Year: 2006

The neck as mediastinal extension: diagnosis of sarcoidosis by core biopsy of cervical lymph nodes
Source: International Congress 2016 – Sarcoidosis
Year: 2016